2019 Q3 Form 10-Q Financial Statement

#000156459019042290 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3 2018 Q2
Revenue $10.66M $11.32M $10.30M
YoY Change -5.8% 4.19% -1.71%
Cost Of Revenue $6.381M $6.744M $6.036M
YoY Change -5.38% 3.88% 0.3%
Gross Profit $4.283M $4.576M $4.268M
YoY Change -6.4% 4.64% -4.41%
Gross Profit Margin 40.16% 40.42% 41.42%
Selling, General & Admin $5.129M $6.487M $6.650M
YoY Change -20.93% 2.98% 37.77%
% of Gross Profit 119.75% 141.76% 155.81%
Research & Development $1.007M $1.149M $901.0K
YoY Change -12.36% -12.95% -32.71%
% of Gross Profit 23.51% 25.11% 21.11%
Depreciation & Amortization $170.0K $220.0K $210.0K
YoY Change -22.73% 4.76% 0.0%
% of Gross Profit 3.97% 4.81% 4.92%
Operating Expenses $6.136M $7.636M $7.550M
YoY Change -19.64% 2.58% 19.41%
Operating Profit -$1.853M -$3.060M -$3.282M
YoY Change -39.44% -0.36% 76.64%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $75.00K -$8.000K $6.000K
YoY Change -1037.5% -50.0% -400.0%
Pretax Income -$1.778M -$3.068M -$3.276M
YoY Change -42.05% -0.62% 76.13%
Income Tax $7.000K $6.000K $4.000K
% Of Pretax Income
Net Earnings -$1.785M -$3.074M -$3.280M
YoY Change -41.93% -0.71% 75.78%
Net Earnings / Revenue -16.74% -27.16% -31.83%
Basic Earnings Per Share -$0.13 -$0.26 -$0.28
Diluted Earnings Per Share -$0.13 -$0.26 -$0.28
COMMON SHARES
Basic Shares Outstanding 13.77M 11.93M 11.64M
Diluted Shares Outstanding 13.77M 11.93M 11.64M

Balance Sheet

Concept 2019 Q3 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.95M $23.73M $16.05M
YoY Change -45.43% -3.5% -32.73%
Cash & Equivalents $12.95M $23.73M $16.05M
Short-Term Investments
Other Short-Term Assets $590.0K $490.0K $650.0K
YoY Change 20.41% 0.0% 14.04%
Inventory $8.896M $8.730M $9.090M
Prepaid Expenses
Receivables $8.784M $8.430M $7.140M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.22M $41.37M $32.93M
YoY Change -24.54% -4.94% -26.85%
LONG-TERM ASSETS
Property, Plant & Equipment $876.0K $1.310M $1.400M
YoY Change -33.13% -16.03% -16.17%
Goodwill $533.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $187.0K $220.0K $170.0K
YoY Change -15.0% 340.0% 112.5%
Total Long-Term Assets $4.740M $2.170M $2.210M
YoY Change 118.43% -4.41% -8.3%
TOTAL ASSETS
Total Short-Term Assets $31.22M $41.37M $32.93M
Total Long-Term Assets $4.740M $2.170M $2.210M
Total Assets $35.96M $43.54M $35.14M
YoY Change -17.41% -4.91% -25.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.429M $2.550M $2.240M
YoY Change -4.75% 43.26% 15.46%
Accrued Expenses $1.634M $5.620M $5.480M
YoY Change -70.93% 21.38% 41.97%
Deferred Revenue $1.528M $1.609M $1.683M
YoY Change -5.03% 14.68%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.299M $10.39M $10.04M
YoY Change -10.5% 34.06% 40.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $17.00K $540.0K $680.0K
YoY Change -96.85% 22.73% 61.9%
Total Long-Term Liabilities $17.00K $540.0K $680.0K
YoY Change -96.85% 22.73% 61.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.299M $10.39M $10.04M
Total Long-Term Liabilities $17.00K $540.0K $680.0K
Total Liabilities $11.97M $10.93M $10.71M
YoY Change 9.52% 33.29% 41.29%
SHAREHOLDERS EQUITY
Retained Earnings -$49.05M
YoY Change
Common Stock $72.94M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.99M $32.61M $24.43M
YoY Change
Total Liabilities & Shareholders Equity $35.96M $43.54M $35.14M
YoY Change -17.41% -4.91% -25.91%

Cashflow Statement

Concept 2019 Q3 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$1.785M -$3.074M -$3.280M
YoY Change -41.93% -0.71% 75.78%
Depreciation, Depletion And Amortization $170.0K $220.0K $210.0K
YoY Change -22.73% 4.76% 0.0%
Cash From Operating Activities -$2.560M -$2.920M -$2.320M
YoY Change -12.33% -435.63% 43.21%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$20.00K -$100.0K
YoY Change 0.0% -80.0% -70.59%
Acquisitions
YoY Change
Other Investing Activities -$120.0K -$110.0K -$100.0K
YoY Change 9.09% 10.0% 25.0%
Cash From Investing Activities -$130.0K -$130.0K -$190.0K
YoY Change 0.0% -27.78% -55.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K 10.65M 30.00K
YoY Change -100.47% 21200.0% -98.61%
NET CHANGE
Cash From Operating Activities -2.560M -2.920M -2.320M
Cash From Investing Activities -130.0K -130.0K -190.0K
Cash From Financing Activities -50.00K 10.65M 30.00K
Net Change In Cash -2.740M 7.600M -2.480M
YoY Change -136.05% 927.03% -2354.55%
FREE CASH FLOW
Cash From Operating Activities -$2.560M -$2.920M -$2.320M
Capital Expenditures -$20.00K -$20.00K -$100.0K
Free Cash Flow -$2.540M -$2.900M -$2.220M
YoY Change -12.41% -398.97% 73.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9083000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187000
CY2019Q3 us-gaap Assets
Assets
35958000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
590000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
547000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
622000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1639000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31133000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
6744000
us-gaap Cost Of Revenue
CostOfRevenue
18367000
CY2018Q3 us-gaap Gross Profit
GrossProfit
4576000
us-gaap Cost Of Revenue
CostOfRevenue
18596000
CY2019Q3 us-gaap Gross Profit
GrossProfit
4283000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1621000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
158000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
25629000
irix Products Warranty Period
ProductsWarrantyPeriod
P2Y
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Transition Report
DocumentTransitionReport
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21194000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12948000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8784000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2763000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88000
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018Q4 us-gaap Assets Current
AssetsCurrent
39618000
CY2019Q3 us-gaap Inventory Net
InventoryNet
8896000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3056000
CY2019Q3 us-gaap Goodwill
Goodwill
533000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2516000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
201000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
100000
CY2018Q4 us-gaap Assets
Assets
41672000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
876000
CY2018Q4 us-gaap Inventory Net
InventoryNet
8794000
CY2018Q4 us-gaap Goodwill
Goodwill
533000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
31218000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1220000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2962000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3154000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4144000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11061000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9959000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
127000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1388000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9299000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2429000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1944000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1634000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10502000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
30522000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
176000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
127000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12362000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2343000
CY2019Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
376000
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1528000
CY2019Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
137000
CY2018Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
238000
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
366000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
586000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2151000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
385000
CY2019Q3 us-gaap Liabilities
Liabilities
11970000
CY2018Q4 us-gaap Liabilities
Liabilities
11711000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
147000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
145000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
72793000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
71548000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
70000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49054000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41802000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
23988000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
29961000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35958000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41672000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
188000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
213000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13778872
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13602052
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13778872
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13602052
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10664000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11320000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31685000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
6381000
us-gaap Gross Profit
GrossProfit
13089000
us-gaap Gross Profit
GrossProfit
12766000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1007000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1149000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2894000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3508000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6491000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-265000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
188000
irix Increase Decrease In Prepaid Deferred Expense And Other Current Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
43000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-86000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1015000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-726000
irix Increase Decrease In Accrued Warranty Liabilities
IncreaseDecreaseInAccruedWarrantyLiabilities
-347000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7974000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
391000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12948000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-11000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
73000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
828000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-175000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
335000
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
302000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
151000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-151000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
72000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8246000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21194000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21707000
irix Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
65000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7209000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
6136000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
7636000
us-gaap Operating Expenses
OperatingExpenses
20446000
us-gaap Operating Expenses
OperatingExpenses
22725000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1853000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3060000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7357000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
75000
irix Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
123000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10558000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2018000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23725000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1778000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
36000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications have been made to the prior year financial statements included in these condensed consolidated financial statements to conform to the current year presentation. The reclassifications had no impact on previously reported net loss or accumulated deficit.</p>
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
24433000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10480000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
673000
CY2018Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
24000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
86000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
32609000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10480000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3068000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7230000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9943000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1785000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3074000
us-gaap Net Income Loss
NetIncomeLoss
-7252000
us-gaap Net Income Loss
NetIncomeLoss
-9957000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13768000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11925000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13682000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11732000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13768000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11925000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13682000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11732000
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
36000
CY2018Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
86000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
32000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
127000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1749000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2988000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7220000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9830000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1398000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
151000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1516000
us-gaap Profit Loss
ProfitLoss
-7252000
us-gaap Profit Loss
ProfitLoss
-9957000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
518000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
617000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
47000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
94000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1398000
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1894000
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
513000
CY2018Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2217000
CY2018Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
608000
CY2018Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1609000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1200000
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
860000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
219000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
232000
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-334000
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-445000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1516000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
567000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-533000
irix Increase Decrease In Prepaid Deferred Expense And Other Current Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
-8000
irix Increase Decrease In Accrued Warranty Liabilities
IncreaseDecreaseInAccruedWarrantyLiabilities
-903000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-331000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-303000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
73000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7724000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
125000
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
318000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10637000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
176000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on our operating results.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are deposited in demand and money market accounts. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and therefore, bear minimal risk.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We market our products to distributors and end-users throughout the world. Sales to international distributors are generally made on open credit terms and letters of credit. Management performs ongoing credit evaluations of our customers and maintains an allowance for potential credit losses. Historically, we have not experienced any significant losses related to individual customers or a group of customers in any particular geographic area. For the three months ended September 28, 2019, no single customer accounted for over 10% of total revenues. For the three months ended September 29, 2018, one customer accounted for more than 10% of total revenues, representing 11%. For the nine months ended September 28, 2019 and September 29, 2018, no single customer accounted for more than 10% of total revenues.&#160;As of September 28, 2019,&#160;one customer accounted for over 10% of our accounts receivable, representing 11%. As of December 29, 2018, no customer accounted for more than 10% of our accounts receivable. &#160;</p>
irix Extended Product Warranty Period
ExtendedProductWarrantyPeriod
P1Y
irix Extended Warranty Threshold Period To Determine Nature Of Sale
ExtendedWarrantyThresholdPeriodToDetermineNatureOfSale
P60D
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2225000
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2520000
irix Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1575000
irix Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1426000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1906000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1729000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1200000
CY2017Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1735000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
298000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
756000
CY2018Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
832000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4000000
CY2018Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4500000
CY2018Q4 irix Deferred Rent Related To Operating Lease
DeferredRentRelatedToOperatingLease
500000
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2424000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2675000
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
811000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1075000
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5661000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5044000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
16000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
16000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
20000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
334000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
572000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
318000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
302000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
47000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
94000
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
63000
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
364000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
381000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1550000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1539000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
317000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3787000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
248000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3539000
CY2019Q3 us-gaap Purchase Obligation
PurchaseObligation
6200000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
158000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
673000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
844898
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
753450
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
210
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
277243
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1320895
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.84
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.86
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.49
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.31
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.47
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.47
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.34
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0158
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0295
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0175
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0271
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.48
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.41
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1161856
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
376412
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.64
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y4M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
71000
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3500000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y14D
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1200000
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-19-042290-index-headers.html Edgar Link pending
0001564590-19-042290-index.html Edgar Link pending
0001564590-19-042290.txt Edgar Link pending
0001564590-19-042290-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
irix-10q_20190928.htm Edgar Link pending
irix-20190928.xml Edgar Link completed
irix-20190928.xsd Edgar Link pending
irix-20190928_cal.xml Edgar Link unprocessable
irix-20190928_def.xml Edgar Link unprocessable
irix-20190928_lab.xml Edgar Link unprocessable
irix-20190928_pre.xml Edgar Link unprocessable
irix-ex311_9.htm Edgar Link pending
irix-ex312_8.htm Edgar Link pending
irix-ex321_6.htm Edgar Link pending
irix-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending